Ann: ResApp Grants Option to Consumer Health Division of Sanofi, page-130

Sanofi has been shopping around for Digital technology to compliment it's array of products. Very recently they have collaborated with a medtech company, Abbot to compliment it's Insulin dozing Smart pen , and another company, Happify, for Multiple sceloris treatment.  

https://www.mobihealthnews.com/news...gets-digital-cutting-new-deals-abbott-happify

The intentions of the Pharma giant, Sanofi has been quite clear-  Collobrate with the latest tech available to suit their business needs i.e push their products.

Very recently they have a new drug "Dupixent" for severe Asthma approved by European Commission
https://www.sanofi.com/en/media-room/press-releases/2019/2019-05-07-15-00-00

May be, just a speculation in my head, our Resapp standalone App  could compliment this product? Not sure about this, only time will tell.

I personally think this is a great move by Resapp. It is not costing them an arm and leg to get this kind of exposure.

All IMO